ly 293111 has been researched along with Inflammation in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adami, F; Agostini, C; Trentin, L | 1 |
Bendele, AM; Cockerham, SL; Froelich, LL; Jackson, WT; Sawyer, JS; Silbaugh, SA; Sofia, MJ; Spaethe, SM; Stengel, PW | 1 |
1 review(s) available for ly 293111 and Inflammation
Article | Year |
---|---|
Chronic obstructive pulmonary disease (COPD): new insights on the events leading to pulmonary inflammation.
Topics: Benzoates; Bronchoalveolar Lavage Fluid; CD8-Positive T-Lymphocytes; Humans; Inflammation; Pulmonary Disease, Chronic Obstructive; Smoking; Tumor Necrosis Factor-alpha | 2003 |
1 other study(ies) available for ly 293111 and Inflammation
Article | Year |
---|---|
Pharmacologic actions of the second generation leukotriene B4 receptor antagonist LY29311: in vivo pulmonary studies.
Topics: Airway Obstruction; Animals; Benzoates; Benzopyrans; Bronchoalveolar Lavage Fluid; Calcimycin; Chemotaxis, Leukocyte; Dinoprostone; Granulocytes; Guinea Pigs; Inflammation; Leukotriene Antagonists; Leukotriene B4; Lung; Male; Receptors, Leukotriene B4; Thromboxane B2 | 2000 |